Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Philadelphia, Pennsylvania

Phase 1 cancer trials in Philadelphia, PA

104 Phase 1 cancer studies are recruiting participants at sites in Philadelphia as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Philadelphia at a glance

  • 104 studies are recruiting at a site in Philadelphia.
  • By phase: Early Phase 1 (5), Phase 1 (49), Phase 1/2 (50).
  • By sponsor: industry (75), university, hospital or other (27), government (2).
  • By research area: Lung Cancer (34), Lymphoma (30), Breast Cancer (17), Prostate Cancer (14), Melanoma (7), Pancreatic Cancer (2).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Philadelphia

Basic details from each study's public record (the 30 most recently updated of 104). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ORIC Pharmaceuticals
    Study site
    University of Pennsylvania
    Registry record
    NCT05315700 · updated
  2. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 19 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    Sidney Kimmell Cancer Center - Jefferson Health
    Registry record
    NCT06586957 · updated
  3. A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study sites
    Fox Chase Cancer Center · University of Pennsylvania
    Registry record
    NCT07213791 · updated
  4. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • Female participants
    Sponsor
    Hoffmann-La Roche
    Study site
    Thomas Jefferson University Hospital
    Registry record
    NCT04802759 · updated
  5. A Phase 1 Study of LNCB74 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LigaChem Biosciences, Inc.
    Study site
    Sidney Kimmel Comprehensive Center at Jefferson
    Registry record
    NCT06774963 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Lung cancer studies recruiting in Philadelphia

  1. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University
    Registry record
    NCT07277413 · updated
  2. Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Abramson Cancer Center at Penn Medicine
    Study site
    Abramson Cancer Center of the University of Pennsylvania
    Registry record
    NCT03760575 · updated
  3. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    Sidney Kimmel Cancer Center
    Registry record
    NCT07458347 · updated
  4. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Univ of Pennsylvania, Abramson Cancer Center
    Registry record
    NCT07020221 · updated
  5. Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

    • Phase 1/2
    • Ages 12 to 85
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Hospital of the University of Pennsylvania
    Registry record
    NCT04959175 · updated
  6. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BlossomHill Therapeutics
    Study site
    Thomas Jefferson University, Sidney Kimmel Cancer Center
    Registry record
    NCT06706076 · updated
  7. A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Sydney Kimmel Cancer Center
    Registry record
    NCT06720987 · updated
  8. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    Fox Chase Cancer Center
    Registry record
    NCT07542704 · updated
  9. First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pierre Fabre Medicament
    Study site
    Thomas Jefferson University Research Facility
    Registry record
    NCT06043817 · updated
  10. KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Abramson Cancer Center of the University of Pennsylvania ( Site 0010)
    Registry record
    NCT04165070 · updated
  11. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Synthekine
    Study site
    Fox Chase Cancer Center
    Registry record
    NCT05098132 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Philadelphia

  1. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    Thomas Jefferson University
    Registry record
    NCT04221542 · updated
  2. First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT07332455 · updated
  3. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Regeneron Pharmaceuticals
    Study site
    Thomas Jefferson University Hospital
    Registry record
    NCT03972657 · updated
  4. A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Sidney Kimmel Cancer Center - Jefferson Health
    Registry record
    NCT05818683 · updated
  5. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Sidney Kimmel Cancer Center - Jefferson Health
    Registry record
    NCT06095089 · updated
  6. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    • Phase 1
    • Ages 18 to 100
    • Male participants
    Sponsor
    Janux Therapeutics
    Study site
    Thomas Jefferson University Honickman Center
    Registry record
    NCT05519449 · updated
  7. FTT PET/CT in Metastatic Prostate Cancer

    • Early Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Abramson Cancer Center at Penn Medicine
    Study site
    University of Pennsylvania Hospital
    Registry record
    NCT05242744 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Lymphoma studies recruiting in Philadelphia

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study sites
    Children's Hospital of Philadelphia · Saint Christopher's Hospital for Children
    Registry record
    NCT04726241 · updated
  2. Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Abramson Cancer Center at Penn Medicine
    Study site
    Abramson Cancer Center, University of Pennsylvania
    Registry record
    NCT07478848 · updated
  3. A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

    • Phase 1
    • Ages 0 to 18
    • All sexes
    Sponsor
    Autolus Limited
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT06173518 · updated
  4. A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Nuvalent Inc.
    Study site
    University of Pennsylvania, Abramson Cancer Center
    Registry record
    NCT05384626 · updated
  5. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of Pennsylvania Abramson Cancer Center
    Registry record
    NCT07101328 · updated
  6. Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

    • Phase 1/2
    • From 6 months, up to 25 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Children's Hospital of Philadelphia (CHOP) ( Site 1021)
    Registry record
    NCT06395103 · updated
  7. A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

    • Early Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AIDS Malignancy Consortium
    Study site
    University of Pennsylvania
    Registry record
    NCT04139304 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Ask about studies near Philadelphia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Pennsylvania

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call